A recent study published in Pathogens reported that an intranasal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine induced mucosal immune responses in mice. Study: Intranasal ...
Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...
As Streptococcus A cases continue to be prevalent, a new nasal vaccine could provide long-term protection from the deadly bacteria. The development of a Strep A vaccine which is currently in Phase 1 ...
Clinical routine utility of basophil activation testing for diagnosis of hymenoptera-allergic patients with emphasis on individuals with negative venom-specific IgE antibodies. Intranasal, ...
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria. Associate Professor Manisha Pandey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results